ZHICHENG BIO
L-Glutamine research directions
Why this compound has a literature
L-Glutamine is the most abundant free amino acid in human plasma and skeletal muscle and serves as a nitrogen carrier, a fuel for rapidly dividing cells, and a substrate in cell-culture media. It is usually described as conditionally essential, meaning that endogenous synthesis has been considered adequate under normal conditions but potentially insufficient during catabolic stress. That framing produced a large clinical research programme in critical care, and the results of the definitive trials in that setting were not what the underlying hypothesis predicted, which is why this literature is worth reading carefully rather than in summary.
What the literature investigates
The critical-care trials and what they returned
Two large randomised trials define this area. Heyland et al. (2013), in the New England Journal of Medicine, randomised 1,223 mechanically ventilated adults with multiorgan failure across forty ICUs to glutamine, antioxidants, both, or placebo delivered both intravenously and enterally. The trial reported a trend toward increased 28-day mortality with glutamine (32.4% vs 27.2%; adjusted odds ratio 1.28) and significantly higher in-hospital and six-month mortality in the glutamine arm, with no effect on organ failure or infectious complications. Andrews et al. (2011), in the BMJ, randomised 502 critically ill adults to parenteral glutamine (20.2 g/day), selenium, or both, and reported no effect of glutamine on new infections or six-month mortality in the intention-to-treat analysis. These results are specific to parenteral and high-dose administration in critically ill populations and do not transfer directly to oral supplementation in healthy adults, but they are the largest and best-powered data in the glutamine literature.
Immune-cell metabolism and the plasma-depletion hypothesis
The mechanistic case for glutamine rests on cellular metabolism. Cruzat et al. (2018) reviewed glutamine metabolism in Nutrients and reported that the rate of glutamine consumption by immune cells is similar to or greater than that of glucose, with availability controlled mainly by key metabolic organs. Walsh et al. (1998) reviewed the exercise-immunology strand in Sports Medicine, reporting that plasma glutamine falls after endurance events and prolonged exercise (against a normal fasted range of 500-750 µmol/L) but is unchanged or temporarily elevated after short-term high-intensity exercise, and that athletes with overtraining syndrome exhibited lower resting plasma glutamine than active controls. That review also noted no consensus had been reached on the best method of determining plasma glutamine as a marker. This is an observational and mechanistic literature; it establishes that glutamine flux changes under stress, not that supplementation corrects a deficit.
Gut permeability trials
Abbasi et al. (2024) published a systematic review and meta-analysis in Amino Acids covering ten clinical trials from 1998 to 2014 with 352 participants of varied health status, all using oral glutamine. Overall, glutamine supplementation did not significantly affect intestinal permeability (weighted mean difference -0.00, 95% CI -0.04 to 0.03). A subgroup analysis at doses above 30 g/day produced a significant reduction, but the underlying trials were few and the populations heterogeneous. The authors called for further investigation across dosages and patient populations. For a formulator, the operative detail is that the dose at which any subgroup signal appeared is well above what a typical recovery powder delivers, and that the pooled result across the ordinary dose range was null.
Sports-nutrition trials and intake-ceiling considerations
Ramezani Ahmadi et al. (2019) published a systematic review and meta-analysis in Clinical Nutrition assessing glutamine supplementation in athletes against body mass, lean body mass, body-fat percentage, VO2max and lymphocyte, leukocyte and neutrophil counts. At the individual-trial level, Legault, Bagnall and Kimmerly (2015) ran a double-blind randomised placebo-controlled crossover in sixteen participants using 0.3 g/kg/day for 72 hours after unilateral knee-extension eccentric exercise and reported greater relative peak torque at 180°/s and lower soreness ratings than isoenergetic placebo, with a larger difference in men than women — a sixteen-person crossover, so an indicative rather than a definitive result. On the upper end of intake, Holeček (2022) reviewed side effects of amino acid supplements and discussed ammonia production and competition for shared membrane carriers as mechanisms relevant to high single-amino-acid intakes.
What this means when you specify the material
Oral trial doses in this literature ranged widely: roughly 0.3 g/kg/day in the recovery study, above 30 g/day in the gut-permeability subgroup, and 20.2 g/day parenterally in critical care. That spread means a published protocol should be matched by route and dose before it is treated as relevant to a consumer product. From a materials standpoint, glutamine is only moderately soluble and is less stable in aqueous systems than most free amino acids, so ready-to-drink and heat-processed formats warrant stability testing that dry-blend formats do not, and the FCC grade specification should be checked against the destination market's own food-additive framework.
Cited literature
Research context only. Each entry describes what a published study examined and reported. These are not claims about this raw material, and not claims about any finished product. Regulatory and labelling judgements belong to the brand placing the product on its market.
- A blinded 2-by-2 factorial randomised trial in 1,223 critically ill adults with multiorgan failure across forty ICUs reported a trend toward increased 28-day mortality with glutamine (32.4% vs 27.2%; adjusted odds ratio 1.28), significantly higher in-hospital and six-month mortality in the glutamine arm, and no effect on organ failure or infectious complications. Heyland D, Muscedere J, Wischmeyer PE, et al. N Engl J Med. 2013;368(16):1489-1497. PMID 23594003DOI 10.1056/NEJMoa1212722
- A randomised double-blind factorial trial in 502 critically ill adults receiving parenteral nutrition reported no overall effect of parenteral glutamine (20.2 g/day) on new infections or six-month mortality in the intention-to-treat analysis. Andrews PJ, Avenell A, Noble DW, et al. BMJ. 2011;342:d1542. PMID 21415104DOI 10.1136/bmj.d1542
- A review of glutamine metabolism reported that the rate of glutamine consumption by immune cells is similar to or greater than that of glucose, and that glutamine availability is controlled mainly by key metabolic organs. Cruzat V, Macedo Rogero M, Noel Keane K, Curi R, Newsholme P. Nutrients. 2018;10(11):1564. PMID 30360490DOI 10.3390/nu10111564
- A review of glutamine, exercise and immune function reported that plasma glutamine (normal fasted range 500-750 µmol/L) falls after endurance events and prolonged exercise but is unchanged or temporarily elevated after short-term high-intensity exercise, that athletes with overtraining syndrome showed lower resting plasma glutamine than active controls, and that no consensus existed on the best method of determining plasma glutamine as a marker. Walsh NP, Blannin AK, Robson PJ, Gleeson M. Sports Med. 1998;26(3):177-191. PMID 9802174DOI 10.2165/00007256-199826030-00004
- A systematic review and meta-analysis of ten clinical trials (352 participants, all oral administration) reported that glutamine supplementation did not significantly affect intestinal permeability overall (weighted mean difference -0.00, 95% CI -0.04 to 0.03), with a significant reduction appearing only in a subgroup analysis of doses above 30 g/day. Abbasi F, Haghighat Lari MM, Khosravi GR, Mansouri E, Payandeh N, Milajerdi A. Amino Acids. 2024;56(1):60. PMID 39397201DOI 10.1007/s00726-024-03420-7
- A systematic review and meta-analysis of clinical trials in athletes assessed glutamine supplementation against body mass, lean body mass, body-fat percentage, VO2max and lymphocyte, leukocyte and neutrophil counts. Ramezani Ahmadi A, Rayyani E, Bahreini M, Mansoori A. Clin Nutr. 2019;38(3):1076-1091. PMID 29784526DOI 10.1016/j.clnu.2018.05.001
- In a double-blind randomised placebo-controlled crossover study in sixteen participants, 0.3 g/kg/day of oral L-glutamine over 72 hours after unilateral knee-extension eccentric exercise was associated with greater relative peak torque at 180°/s and lower muscle soreness ratings at 24, 48 and 72 hours than isoenergetic placebo, with a larger difference reported in men than women. Legault Z, Bagnall N, Kimmerly DS. Int J Sport Nutr Exerc Metab. 2015;25(5):417-426. PMID 25811544DOI 10.1123/ijsnem.2014-0209
- A review of the side effects of amino acid supplements examined glutamine among other amino acids and discussed ammonia production and competition for shared membrane carriers as mechanisms relevant to high intakes. Holeček M. Physiol Res. 2022;71(1):29-45. PMID 35043647DOI 10.33549/physiolres.934790
Need this grade for your line?
Research context only. Each entry describes what a published study examined and reported. These are not claims about this raw material, and not claims about any finished product. Regulatory and labelling judgements belong to the brand placing the product on its market.